← Browse by Condition

Medical Condition

sepsis

Total Trials

26

Recruiting Now

26

Trial Phases

Phase 1, Phase 4, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for sepsis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — sepsis Clinical Trials

How many clinical trials are currently recruiting for sepsis?

ClinicalMetric currently tracks 26 actively recruiting clinical trials for sepsis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 26. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for sepsis?

sepsis research spans Phase 1 (2 trials), Phase 2 (1 trial), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a sepsis clinical trial?

Eligibility criteria for sepsis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

2

Phase 2

1

Phase 4

2

Top Sponsors

Ain Shams University 2 trials

Uppsala University 2 trials

Bayer 1 trial

Taipei Veterans General Hospital, Taiwan 1 trial

Kirby Mayer 1 trial

Recruiting Clinical Trials

NCT06854640 Phase 1

A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy

Belgium, France, Ger...

Observational Study About the Use of Perfusion Index to Use Vasopressor in Sepsis

Ain Shams University

NCT04140578 Phase 4

Antibiotic Prophylaxis in Patients Undergoing GVO

Taipei Veterans General Hospit...

Virtual Reality in ICU - PARTNER

Rapid Recognition of Corticosteroid Resistant or Sensitive Sepsis

Assistance Publique - Hôpitaux...

Hemodynamic Evaluation Using Microcirculation for Early Treatment of Septic Patients

University Hospital, Limoges

TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections

Role of Transposable Elements in Septic Immune Aging

University of California, San ...

Inflammatory Mediators of Acute Kidney Injury in Intensive Care

Uppsala University

UMMS Sepsis Early Prediction Score (SEPSys) and RESCUE Score Combined Clinical Trial

University of Maryland, Baltim...

Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates

United States, Kenya

University of California, Berk...

Efficacy of SGLT2 Inhibitors in Adults With Sepsis

Hospital Authority, Hong Kong

Detection of Sepsis Occurrence by Using Blood Fluorescence

Zhujiang Hospital

HO-1/CREB3 Modulates Golgi Stress in Patients With Sepsis

Tianjin Nankai Hospital

The Effects of Endotracheal Suctioning on Pain and Serum Markers

Loma Linda University

NCT06570187 Phase 4

The Effect of Dexmedetomidine on the Renal Functions in Septic Critically Ill Patients

Cairo University

NCT07236463 Phase 1, Phase 2

Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury

Centre Hospitalier Universitai...

Effect of Albumin Replacement on Oxygen Delivery in Sepsis Patients

Turkey (Türkiye)

Samsun University

Effect of oXiris Hemofilter Use in Septic Shock: A Multicenter Retrospective Cohort Study

Seoul National University Bund...

Defining Volume Status in Sepsis With Extracellular Water Measurement

Uppsala University

Febrile Infants Swedish Study

Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children

Children's Hospital of Fudan U...

Early Norepinephrine Administration and Rapid Dose Adjustment

Siriraj Hospital

Stratifying Critically Ill Patients for Novel Ferroptosis or Pyroptosis Intervention Strategies

University Hospital, Antwerp

Retrospective Analysis of Chest X-ray Severity Scoring System of COVID-19 Pneumonia

Osijek University Hospital

A Comparative Study Between Neutrophil/Lymphocyte Ratio and Lactate/Albumin Ratio as Predictive Inflammatory Markers for Sepsis

Ain Shams University

Related Conditions

acute kidney injury (3) septic shock (3) fever (2) serious bacterial infection (2) pneumonia (2) multiorgan failure (2) coagulopathy (1) perfusion index (1) vasopressor (1) gastric varix (1) liver cirrhoses (1) acute respiratory failure (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology